TOXICOLOGY AND APPLIED PHARMACOLOGY, published by Academic Press, Inc. Elsevier Science, stands as a leading journal in the domains of toxicology and pharmacology, with its establishment dating back to 1959. With an impact factor reflecting its academic rigor and relevance, this journal is classified in the Q2 quartile for both pharmacology and toxicology categories, underscoring its significance in the scientific community. It ranks #34 out of 133 in Toxicology and #95 out of 313 in Pharmacology according to Scopus, placing it within the 74th and 69th percentiles, respectively. The journal aims to disseminate quality research that drives advancements in understanding the interactions of drugs and toxic substances within biological systems. Researchers and professionals are invited to contribute and engage with a broad spectrum of articles that cover mechanistic studies, risk assessment, and innovative therapeutic strategies. Although the journal does not offer open access, it continues to be a crucial resource for those who seek to navigate the complex interface of drugs and their toxicological implications.

TOXICOLOGY IN VITRO is a premier journal published by PERGAMON-ELSEVIER SCIENCE LTD, focusing on the latest advancements in the field of toxicology, particularly through in vitro methodologies. With an ISSN of 0887-2333 and an E-ISSN of 1879-3177, this journal serves as a critical platform for researchers aiming to disseminate their findings in toxicology, emphasizing innovative approaches and applications in pharmacology and toxicology. Featuring a commendable impact factor and classified in the second quartile (Q2) for both Medicine (miscellaneous) and Toxicology in 2023, the journal holds a significant position within the academic community, ranking 41st out of 133 in the Toxicology category according to Scopus, representing the 69th percentile. Despite being a subscription-based publication, it continuously attracts submissions from leading scientists worldwide, fostering a vibrant exchange of scientific knowledge. Since its inception in 1987, TOXICOLOGY IN VITRO has consistently aimed to enhance understanding of toxicological challenges, making it an invaluable resource for professionals, students, and researchers dedicated to developing safer pharmaceuticals and understanding the biological pathways influenced by potential toxic agents.

TOXICOLOGICAL SCIENCES, published by Oxford University Press, is a premier journal in the field of toxicology that has been a cornerstone of scientific discourse since its inception in 1981. With an impressive 2023 impact factor and ranked in the Q1 category for Toxicology, this journal is highly regarded among researchers, professionals, and students dedicated to pharmacology and toxicology. The journal is committed to advancing the understanding of toxicological science, covering a breadth of topics that include the mechanisms of toxicity, risk assessment, and the regulatory aspects affecting public health. With an ISSN of 1096-6080 and an E-ISSN of 1096-0929, TOXICOLOGICAL SCIENCES facilitates open access scholarly work, ensuring that critical research reaches a global audience and promotes collaborative learning. As it converges towards 2024, the journal remains pivotal in shaping the future of toxicology research, providing insights that are essential for developing safer chemicals and protecting environmental health.

The Journal of Toxicological Sciences, published by the Japanese Society of Toxicological Sciences, is a prominent academic journal dedicated to the comprehensive study of toxicology and its related fields. Since its inception in 1976, the journal has provided a vital platform for researchers and professionals to disseminate innovative findings and insights in toxicology, with a focus on both experimental and clinical studies. Positioned in the Q3 quartile across various relevant categories, including Medicine (miscellaneous) and Toxicology as of 2023, the journal plays an essential role in advancing our understanding of toxic substances and their effects on biological systems. Although currently not open access, the journal maintains high academic standards and is indexed in Scopus, ranking #96 in Toxicology. Offering unique perspectives from Japan, it encourages global collaboration and discourse among toxicologists, making it an invaluable resource for students, researchers, and industry professionals alike.

The International Journal of Toxicology, published by SAGE Publications Inc, serves as a cornerstone of scholarly research in the field of toxicology, with an established history dating back to 1982. This esteemed journal, ISSN 1091-5818 and E-ISSN 1092-874X, functions within the Q3 quartile in Toxicology, ranking 94 out of 133 in the Pharmacology, Toxicology and Pharmaceutics category per Scopus metrics, reflecting its commitment to advancing scientific understanding in this critical area. The journal not only aims to disseminate high-quality research but also encourages open access to vital studies, thus fostering collaboration and innovation among researchers, professionals, and students alike. With a focus on various aspects of toxicology, including but not limited to environmental, clinical, and molecular toxicology, the International Journal of Toxicology is dedicated to bridging gaps in toxicity research and promoting safe practices across numerous disciplines. As it converges towards 2024, the journal continues to play a vital role in shaping the discourse surrounding the implications of exposure to toxic substances in human health and the environment.

Current Opinion in Toxicology is a premier academic journal published by Elsevier, focusing on the latest advancements and perspectives in the field of toxicology. With an impressive impact factor reflecting its high citation and influence within the research community, this journal ranks in the Q1 category for Toxicology, positioned at #8 out of 133 in the Scopus Toxicology domain, placing it in the 94th percentile. The journal aims to provide concise and insightful reviews of contemporary research, fostering an understanding of critical issues related to toxic effects of chemicals and environmental agents. Although not an open access journal, it attracts a worldwide readership, making it an essential resource for researchers, professionals, and students committed to understanding toxicological science. Based in the Netherlands, Current Opinion in Toxicology serves as a platform for stimulating scholarly dialogue and guiding future research directions in this vital area of study.

ARCHIVES OF TOXICOLOGY is a prestigious journal published by Springer Heidelberg, dedicated to advancing research in the field of toxicology and related disciplines. With a distinguished history dating back to 1930, this journal has continuously provided vital insights and groundbreaking studies, making it a cornerstone in the areas of health, toxicology, and medicine. Recognized for its high impact, it occupies a top-ranking position in Scopus, with remarkable quartile placements in 2023, categorizing it as Q1 in Health, Toxicology and Mutagenesis, and Q1 in Medicine (Miscellaneous). The journal highlights critical research and innovative methodologies, appealing to a diverse audience of researchers, professionals, and students committed to understanding the complexities of toxic substances and their implications for public health and environmental safety. The journal does not currently offer open access, allowing for a more traditional but rigorous peer-review process that ensures the quality and integrity of every published article. Join the global discourse in toxicological science with ARCHIVES OF TOXICOLOGY, where every contribution furthers the understanding of safety and toxicity in our world.

CRITICAL REVIEWS IN TOXICOLOGY, published by Taylor & Francis Ltd, stands as a preeminent journal within the field of toxicology, boasting an impressive Q1 ranking and holding the distinction of being ranked 12th out of 133 in the toxicology category according to Scopus, placing it in the top 91st percentile. With a continuous publication history since 1971 and a commitment to providing high-quality reviews, the journal offers critical insight into the latest research and advancements in toxicological sciences. While it is not an open-access journal, it provides numerous access options for both subscribers and institutions, ensuring that its extensive articles are widely available to the academic community. The journal's objectives are to disseminate comprehensive reviews that foster understanding and innovation in the assessment of chemical risks, environmental impacts, and the mechanisms of toxicity, making it an invaluable resource for researchers, professionals, and students dedicated to the science of toxicology.

TOXICOLOGICAL AND ENVIRONMENTAL CHEMISTRY is a pivotal journal published by Taylor & Francis Ltd, addressing critical intersections between environmental chemistry and toxicology since its inception in 1979. With its ISSN 0277-2248 and E-ISSN 1029-0486, the journal serves as a platform for rigorous research and innovative methodologies in pollution control, health implications of environmental chemicals, and the broader spectrum of toxicological studies. Although it currently does not offer open access, the journal's impact in the field is underscored by its Category Quartiles rankings in 2023, placing it in Q3 across Environmental Chemistry, Health, Toxicology and Mutagenesis, and Pollution categories. Furthermore, its Scopus rankings reveal its significant role within the scientific community, specifically in areas such as Environmental Science and Toxicology. The journal aspires to foster multidisciplinary dialogue and advance knowledge that contributes to environmental sustainability and public health, making it an essential resource for researchers, professionals, and students dedicated to these fields.

TOXICOLOGIC PATHOLOGY, published by SAGE Publications Inc., is a dedicated journal that serves as a pivotal platform for researchers and professionals in the fields of toxicology and pathology. With an ISSN of 0192-6233 and E-ISSN of 1533-1601, the journal has been committed to advancing knowledge since its inception in 1972. It boasts impressive rankings in the recent 2023 category quartiles, achieving Q2 in Pathology and Forensic Medicine, and Q3 in Cell Biology, Molecular Biology, and Toxicology, marking it as a significant contributor to these vital disciplines. Despite its non-open access status, the journal ensures accessibility through various premium library subscriptions, providing readers with essential insights on toxicologic and pathologic research, advancing both academic inquiry and practical applications. Researchers, students, and industry professionals alike will find TOXICOLOGIC PATHOLOGY an indispensable resource, offering high-quality peer-reviewed articles that explore the complex interactions between substances and biological systems, with the aim of improving public health and safety.